Finding Ways To Beat The Productivity Paradox

Scientists as a rule are very busy, conducting experiments and analysis, plotting data, giving talks, writing, and advising. However, much of their work never makes it into print. A large percentage of published abstracts never become finished papers. Drawers full of data are collected but never analyzed. This is the productivity paradox in science: Why, among professionals whose time is largely under their own control, is so much of their effort apparently wasted? I believe we can discover t

Written byCraig Loehle
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Craig Loehle Scientists as a rule are very busy, conducting experiments and analysis, plotting data, giving talks, writing, and advising. However, much of their work never makes it into print. A large percentage of published abstracts never become finished papers. Drawers full of data are collected but never analyzed. This is the productivity paradox in science: Why, among professionals whose time is largely under their own control, is so much of their effort apparently wasted?

I believe we can discover the cause of this paradox if we dissect the process of producing a finished scientific product. It is rare that a scientific product is completed in one simple step of discovery. It is far more likely that many steps or stages must be completed successfully. It is not enough to have a good idea. One also must figure out how to test the concept, competently carry out the experiment, carefully record the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies